Press release content from Business Wire. The AP news staff was not involved in its creation.

Helicobacter Pylori Testing Global Market Report 2022: Danger of Peptic Ulcers and Gastric Cancer Drives Adoption -

PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.
December 19, 2022 GMT

DUBLIN--(BUSINESS WIRE)--Dec 19, 2022--

The “Helicobacter Pylori Testing: Global Market Outlook” report has been added to’s offering.

The report provides an overview of the global Helicobacter pylori testing market and analyzes market trends. Using 2021 as the base year, the report provides estimated market data for the forecast period of 2022 to 2027. Market values are estimated based on the total revenue of H. pylori testing product providers.

One of the most common chronic bacterial infections, Helicobacter pylori affects more than one-third of the U.S. population. If not detected and treated in time, the bacteria can damage gastric mucosa, leading to peptic ulcers or gastric cancer. Common symptoms of the infection include heartburn, dyspepsia, stomach pain, bloating and indigestion; however, these symptoms can also be associated with other gastrointestinal (GI) conditions such as peptic ulcer disease (PUD), gastritis, gastroesophageal reflux disease (GERD), or even gastric cancer.


Increasing cases of gastric ulcers, the rising prevalence of H. pylori infection in the geriatric population, and growing demand for point-of-care testing devices are the key factors driving the growth of the Helicobacter pylori testing market. However, a lack of awareness regarding H. pylori infection is hindering the market’s growth.

In this report, the global Helicobacter pylori testing market is segmented based on test type, end user and geography. Based on test type, the market has been categorized into serology testing, stool antigen testing (SAT), urea breath testing (UBT), and others.

Based on end user, the Helicobacter pylori testing market is segmented into hospitals and clinics, and diagnostic centers.

By geography, the Helicobacter pylori testing market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. The presence of leading global companies, technology infrastructure, a favourable political and economic environment, and a surge in demand for point-of-care devices are some of the key factors driving the North American market. Asia-Pacific is currently the fastest-growing market for Helicobacter pylori testing for the forecast period.


Report Includes

  • An overview of the global market outlook for Helicobacter pylori (H. pylori) testing
  • Analyses of the global market trends, with historic market revenue data for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the market potential for Helicobacter pylori testing products, industry growth drivers, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of the actual market size and revenue forecast for helicobacter pylori testing market in USD million terms, and corresponding market share analysis by test type, end-user, and region
  • In-depth information (facts and figures) concerning the major market dynamics, industry structure, and competitive environment of the leading market participants
  • Market outlook and assessment of the recent strategic analysis in the global helicobacter pylori testing market with emphasis on key developments
  • Company profiles of the leading industry players


Key Topics Covered:

Chapter 1 Market Outlook

Chapter 2 Executive Summary

Chapter 3 Market Overview

Chapter 4 Market Breakdown by Test Type and End-user

Chapter 5 Market Breakdown by Region

Chapter 6 Industry Structure

Chapter 7 Company Profiles

Chapter 8 Project Scope and Methodology

Companies Mentioned

  • Abbott
  • Advacare Pharma
  • Ama-Med Oy
  • Biomerica
  • Certest Biotec Sl
  • Coris Bioconcept
  • Diasorin Spa
  • Jant Pharmacal Corp.
  • Meridian Bioscience Inc.
  • Sekisui Diagnostics
  • Thermo Fisher Scientific

For more information about this report visit

View source version on


Laura Wood, Senior Press Manager

press@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470


For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2022.

PUB: 12/19/2022 11:30 AM/DISC: 12/19/2022 11:32 AM